HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) An erratum has been published All Versions of this Article: jnumed.107.039933v1 48/7/1154    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ryu, Y. H. Articles by Innis, R. B. Search for Related Content PubMed PubMed Citation Articles by Ryu, Y. H. Articles by Innis, R. B.

Disulfiram Inhibits Defluorination of ¹⁸F-FCWAY, Reduces Bone Radioactivity, and Enhances Visualization of Radioligand Binding to Serotonin 5-HT_1A Receptors in Human Brain

¹ Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland; ² Department of Nuclear Medicine, Yonsei University Medical College, Seoul, South Korea; and ³ National Cancer Institute, National Institutes of Health, Bethesda, Maryland

Correspondence: For correspondence contact: Robert Innis, MD, PhD, Molecular Imaging Branch, National Institute of Mental Health, Building 31, Room B2B37, 31 Center Dr., Bethesda, MD 20892-2035. E-mail: robert.innis{at}nih.gov

¹⁸F-trans-4-Fluoro-N-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-(2-pyridyl)cyclohexanecarboxamide (¹⁸F-FCWAY) is a PET radioligand for imaging serotonin 5-hydroxytryptamine-1A receptors in brain. ¹⁸F-FCWAY undergoes significant defluorination, with high uptake of radioactivity in the skull and resulting spillover contamination in the underlying neocortex. The cytochrome P450 enzyme CYP2E1 defluorinates many drugs. We previously showed that miconazole, an inhibitor of CYP2E1, blocks defluorination of FCWAY in rats. Here, we used ¹⁸F-FCWAY to test the ability of the less toxic agent disulfiram to inhibit defluorination in humans. Methods: Eight healthy volunteers underwent a PET scan before and after administration of 500 mg of disulfiram (n = 6) or 2,000 mg of cimetidine (n = 2). Seven of the subjects had arterial blood sampling during both scans. Results: Although cimetidine had relatively small and variable effects on 2 subjects, disulfiram reduced skull radioactivity by about 70% and increased peak brain uptake by about 50% (n = 5). Disulfiram decreased plasma-free ¹⁸F-fluoride ion (from peak levels of 340% ± 62% standardized uptake value (SUV) to 62% ± 43% SUV; P < 0.01) and increased the concentration of the parent ¹⁸F-FCWAY (with a corresponding decrease of clearance from 14.8 ± 7.8 L·h^–1 at baseline to 7.9 ± 2.8 L·h^–1 after drug treatment (P < 0.05). Using compartmental modeling with input of both ¹⁸F-FCWAY and the radiometabolite ¹⁸F-FC (trans-4-fluorocyclohexanecarboxylic acid), distribution volumes attributed to the parent radioligand unexpectedly decreased about 40%–60% after disulfiram, but the accuracy of the radiometabolite correction is uncertain. Disulfiram changed the shape of the brain time–activity curves in a manner that could occur with inhibition of the efflux transporter P-glycoprotein (P-gp). However, disulfiram showed no in vivo efficacy in monkeys to enhance the uptake of the known P-gp substrate ¹¹C-loperamide, suggesting that the effects of disulfiram in humans were mediated entirely by inhibition of CYP2E1. Conclusion: A single oral dose of disulfiram inhibited about 70% of the defluorination of ¹⁸F-FCWAY, increased the plasma concentration of ¹⁸F-FCWAY, increased brain uptake of activity, and resulted in better visualization of 5-HT_1A receptor in the brain. Disulfiram is a safe and well-tolerated drug that may be useful for other radioligands that undergo defluorination via CYP2E1.

Key Words: metabolism • ¹⁸F-FCWAY • 5HT_1A receptor • PET • disulfiram • defluorination • serotonin

COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.

Related articles in JNM:

This Month in JNM

JNM 2007 48: 11a-12a. [Full Text]  

This article has been cited by other articles:

				G. Giovacchini, S. Conant, P. Herscovitch, and W. H. Theodore Using Cerebral White Matter for Estimation of Nondisplaceable Binding of 5-HT1A Receptors in Temporal Lobe Epilepsy J. Nucl. Med., November 1, 2009; 50(11): 1794 - 1800. [Abstract] [Full Text] [PDF]

				H. U. Shetty, S. S. Zoghbi, F. G. Simeon, J.-S. Liow, A. K. Brown, P. Kannan, R. B. Innis, and V. W. Pike Radiodefluorination of 3-Fluoro-5-(2-(2-[18F](fluoromethyl)-thiazol-4-yl)ethynyl)benzonitrile ([18F]SP203), a Radioligand for Imaging Brain Metabotropic Glutamate Subtype-5 Receptors with Positron Emission Tomography, Occurs by Glutathionylation in Rat Brain J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 727 - 735. [Abstract] [Full Text] [PDF]